Oberadilol
Alternative Names: TZC 5665Latest Information Update: 07 Jun 2005
At a glance
- Originator Teikoku Hormone
- Class Antihypertensives; Peripheral vasodilators; Pyridazines; Small molecules
- Mechanism of Action Beta adrenergic receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Heart failure; Hypertension
Most Recent Events
- 01 May 2005 Discontinued - Phase-II for Heart failure in Japan (unspecified route)
- 09 Oct 1998 TZC 5665 is now called oberadilol (Rec INN)
- 02 Aug 1995 Discontinued-Preclinical for Hypertension in Japan (Unknown route)